Rare genetic liver conditions like progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome pose a substantial financial and quality-of-life…
Articles by Michela Luciano, PhD
A once-monthly investigational therapy for metabolic dysfunction-associated steatohepatitis (MASH), called efimosfermin, has earned two new regulatory designations — one in…
The U.S. Food and Drug Administration (FDA) has accepted and placed under priority review an application seeking approval of bepirovirsen,…
Scheduled MRI scans one to three years after a liver transplant may detect signs of returning primary sclerosing cholangitis (PSC)…
Noninvasive scores originally developed to assess liver scarring may help diagnose pregnant women who have intrahepatic cholestasis of pregnancy…
April 19 marks World Liver Day, a global effort to raise awareness about liver health and the growing burden…
The European Medicines Agency (EMA) has started its formal review of bepirovirsen, a move that could introduce a new class…
A noninvasive MRI-based approach may help assess disease severity and predict the likelihood of serious complications in people with…
A noninvasive liver scan used alongside a standard blood test may accurately predict the severity of liver scarring, or fibrosis,…
People with hepatitis C who show higher values of liver scarring markers before starting antiviral therapy are significantly more…